Skip to main content
Premium Trial:

Request an Annual Quote

People In The News : Apr 26, 2013

NEW YORK (GenomeWeb News) – Patrick Tan, a researcher at A*STAR's Genome Institute of Singapore, has been awarded the 2013 Chen New Investigator Award from the International Human Genome Organization. HUGO selected Tan as a winner of this award based on his contributions to research into the genomic profiles of cancer in people of Asian ancestry.

Tan currently is leading the Personalized Omic Lattice for Advanced Research and Improving Stratification consortium, and he is a professor in the Cancer and Stem Cell Biology Program at the Duke-National University of Singapore Graduate Medical School and a senior principal investigator at the Cancer Institute of Singapore and at the NUS.


The Wellcome Trust said this week that it has named Jeremy Farrar to be the new director of the institute, replacing Mark Walport, who has become the UK Government's chief science adviser.

Farrar has been director of the Oxford University Clinical Research Unit in Vietnam, which is funded by the Wellcome Trust and by Vietnam. He will step into the top post in October, and until then Ted Bianco, director of technology transfer, will serve as acting director.


Illumina this week named Charles Dadswell as senior vice president and general counsel.

Dadswell takes over for Christian Cabou, who has retired. He will have worldwide responsibility for all legal and IP matters, and will serve as secretary to Illumina's board of directors.

Dadswell joins Illumina from BioMérieux, where he was most recently vice president, general counsel for North and Latin America and corporate director of global intellectual property.

Prior to BioMérieux, he was general counsel of BioDelivery Sciences International; and oversaw US intellectual property in a variety of positions with Glaxo, GlaxoWellcome, and GlaxoSmithKline.


Cepheid disclosed during its first-quarter earnings call last week that Warren Kocmond will join the company on May 6 as executive vice president of global operations.

Kocmond is currently vice president of global operations for Lam Research, and has previously served as executive vice president of memory products at Verigy; CEO of Electroglas; and senior vice president of global operations at Affymetrix.


Nanosphere said this week that it has appointed Ken Bahk to be chief strategy officer, a new position, and that company Chief Technology Officer Tim Patno will be leaving the company, as will Chad Mirkin, a member of the board of directors.

Bahk was part of Nanosphere's initial team, and served with the company until 2008. In the new post, he will be responsible for driving strategic plans and revenues in molecular diagnostics.

He currently is a director of investments at Lurie Investments, where he focuses on the diagnostics and life sciences areas. He also formerly was chair of strategic opportunities for the Association for Molecular Pathology.


PerkinElmer shareholders have elected eight nominees for its board of directors for one-year terms including Peter Barrett; Robert Friel; Nicholas Lopardo; Alexiz Michas; James Mullen; Vicki Sato; Kenton Sicchitano; and Patrick Sullivan.


Life Technologies said in a filing with the US Securities and Exchange Commission that Arnold Levine has retired from its board of directors, and that the company's stockholders have elected George Adam; Raymond Dittamore; Donald Grimm; Craig Mundie; Ora Pescovitz; and Per Peterson to serve on the board until the 2014 meeting.


Precision for Medicine has hired Harry Glorikian and Karen Becker to serve as managing directors.

Glorikian is the co-founder of Scientia Advisors, a healthcare and life sciences advisory firm that was acquired be Precision in 2012, and Becker was CEO of Becker and Associates, a regulatory strategy company focused on the biopharmaceutical and medical device industries.


Stanford University School of Medicine Associate Professor Atul Butte has been named as an advisor for the San Francisco angel investor and strategic advice shop SV Angel.

The investment firm appointed Butte for his expertise in applying computer and data science to biomedical research, one of its areas of focus.


Promoted? Changing jobs? GenomeWeb wants to know. [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.